glucose, (beta-d)-isomer has been researched along with Ear Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garssen, J; Graus, YM; Hartog, A; Hoijer, MA; Hougee, S; Sanders, A; Smit, HF; van Beuningen, HM; van den Berg, WB | 1 |
Ji, LL; Liu, J; Wang, ZT | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Ear Diseases
Article | Year |
---|---|
Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice.
Topics: Acetophenones; Administration, Oral; Animals; Arthritis; Blood Cells; Cartilage, Articular; Dinoprostone; Drinking; Ear Diseases; Enzyme Inhibitors; Female; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NADPH Oxidases; Proteoglycans; Zymosan | 2006 |
In vivo and in vitro anti-inflammatory activities of neoandrographolide.
Topics: Animals; Capillary Permeability; Cell Line; Cell Survival; Diterpenes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ear Diseases; Edema; Glucosides; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; Respiratory Burst; Tetrahydronaphthalenes; Tumor Necrosis Factor-alpha | 2007 |